Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY
$7.34
-$0.26-3.42%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.28% | 3.12% | 2.87% | 3.95% | 3.64% |
| Total Other Revenue | -2.09% | -2.09% | -6.56% | 3.88% | -8.28% |
| Total Revenue | 6.25% | 3.10% | 2.84% | 3.95% | 3.58% |
| Cost of Revenue | 6.14% | 3.49% | 3.41% | 4.70% | 4.45% |
| Gross Profit | 7.14% | -0.01% | -1.80% | -2.01% | -3.11% |
| SG&A Expenses | 10.24% | 2.13% | -1.46% | -3.13% | -8.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 363.14% | 349.68% | -50.33% | -81.13% | -73.63% |
| Total Operating Expenses | 6.54% | 3.53% | 2.91% | 3.87% | 3.39% |
| Operating Income | -2.04% | -9.13% | 0.63% | 6.36% | 9.72% |
| Income Before Tax | 31.91% | 22.25% | 34.26% | 36.41% | 10.00% |
| Income Tax Expenses | 39.28% | 32.37% | 45.85% | 37.87% | 9.99% |
| Earnings from Continuing Operations | 29.15% | 18.55% | 29.96% | 35.87% | 10.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -7.79% | 4.95% | 2.09% | 3.79% | -0.27% |
| Net Income | 35.56% | 25.35% | 39.59% | 47.92% | 13.31% |
| EBIT | -2.04% | -9.13% | 0.63% | 6.36% | 9.72% |
| EBITDA | 0.65% | -5.95% | 2.26% | 7.05% | 9.35% |
| EPS Basic | 35.98% | 25.26% | 39.91% | 46.82% | 11.84% |
| Normalized Basic EPS | 39.40% | 34.71% | 60.00% | 68.77% | 21.94% |
| EPS Diluted | 35.99% | 25.24% | 40.27% | 47.87% | 11.97% |
| Normalized Diluted EPS | 39.40% | 34.71% | 60.00% | 68.77% | 21.94% |
| Average Basic Shares Outstanding | -0.09% | 0.15% | -0.89% | 0.12% | 0.52% |
| Average Diluted Shares Outstanding | -0.09% | 0.15% | -0.89% | 0.12% | 0.52% |
| Dividend Per Share | 28.65% | 28.65% | -16.08% | -16.08% | -9.68% |
| Payout Ratio | -0.36% | -0.38% | -0.41% | -0.41% | -0.22% |